Computer system goes out at Tennova hospital system after database deleted
Tennova Healthcare, owner of six medical centers in Middle and East Tennessee, experienced an internal computer system outage that has forced workarounds for thousands of staff members across the company.
The hospital network is using "downtime procedures that are used in the event of a system outage," which generally means using a pencil and paper to chart patient care.
No hospital operations or services have stopped due to the outage, Tennova marketing coordinator Rylee Sawyer told Knox News. Sawyer also said the outage is not due to a cyber attack, but was caused by the accidental deletion of a critical database.
"Cerner engineers mistakenly deleted critical storage connected to a key database, leading to an outage," Sawyer said.
Cerner is the internal computer system that Tennova, and many others around the U.S. use to keep track of electronic health records. Cerner is owned by Oracle Health, the second largest shareholder in the business, according to EHR in Practice.
No patient data was affected, Sawyer said.
Tennova hospitals, all in Tennessee, are:
Jefferson Memorial Hospital in Jefferson City
LaFollette Medical Center in LaFollette
Newport Medical Center in Newport
North Knoxville Medical Center in Powell
Tennova Healthcare - Clarksville in Clarksville
Turkey Creek Medical Center in Knoxville
Allison Kiehl covers breaking and trending news for Knox News. Email: allison.kiehl@knoxnews.com.
This article originally appeared on Knoxville News Sentinel: Computer system out at Tennova hospital system after database deleted
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28-05-2025
- Yahoo
Butt-lift injector banned from carrying out procedures
A self-styled "beauty consultant" who specialises in liquid Brazilian butt-lifts (BBLs) has been banned from carrying out any form of cosmetic surgery across England and Wales following a BBC investigation. Ricky Sawyer was found to be performing risky BBL treatments - which involve injecting up to 1,000ml of dermal filler into clients' buttocks to make them look bigger. He was exposed while working in a rented office block in London, performing dangerous procedures and handing over medication illegally. The BBC's findings were submitted to Manchester Civil Justice Centre as part of a civil action brought forward by Trafford Council. On Wednesday a judge granted an injunction against Mr Sawyer, banning him from carrying out or arranging cosmetic surgeries in England and Wales until 27 May 2028. The court heard evidence that included video footage from the BBC's original documentary, and graphic pictures of one of Mr Sawyer's client's injuries. James Parry, the lawyer who brought the case on behalf of Trafford Council, told the judge that the injuries were akin to that of "serious knife crime". Mr Parry later told the BBC: "I think that the level of injury that people have suffered and have produced evidence of their suffering of is quite shocking." Judge McAdam, in granting the injunction, agreed that the images were "shocking" and concluded that the breadth of the order was necessary to prevent further public harm. The injunction prohibits Mr Sawyer from undertaking or facilitating any invasive cosmetic procedures, including but not limited to the BBL, anywhere in England and Wales. It also bars him from possessing related surgical equipment or any antibiotics typically used in such treatments, unless prescribed for his own use. The court attached a power of arrest to key clauses in the order, meaning police may arrest Mr Sawyer without a warrant if he is found to be in breach of its terms. Mr Sawyer has been given 21 days to challenge the injunction. The BBC has heard testimony from nearly 40 women who reported serious complications, including sepsis and necrosis, after undergoing procedures by Mr Sawyer. Ashley, 27, attended one of Mr Sawyer's pop-up clinics last spring, and said she was drawn to Mr Sawyer by his low prices and celebrity endorsements. She travelled from her home in Liverpool to London and was directed to an office block. Despite misgivings about the location, she decided to go through with it. She said that after the injections started the pain was instant. "I nearly fainted" she said. At one point Ashley turned around and saw Mr Sawyer covered in blood. "He butchered me, there is no other word for it." Ashley said she left the clinic barely able to walk and covered in blood. Three days later, she was rushed to hospital with an infection and told she could have died without treatment. While Ashely has made a full recovery her voice still shakes when she recounts the experience at Mr Sawyer's hands. Reacting to Wednesday's court proceedings, Ashley said: "I am relieved, it makes me feel that we're being taken seriously." Several councils have banned Mr Sawyer from practising in their areas. And since the BBC documentary aired three further councils - Trafford, Salford and Manchester - have also banned him. Trafford Council said it would continue to monitor compliance with the injunction and encouraged anyone with information about unlawful cosmetic procedures to come forward.
New York Times
27-05-2025
- New York Times
I Got My Clothes Coated With Insect Shield Tick Killer
Wirecutter's resident bug expert, Doug Mahoney, has written that he uses permethrin spray on his family's socks and shoes. In that article, he cites one study's finding that people who wore treated footwear were 74 times less likely to get a bite from a tick nymph than those who did not. 'I take the hint from that study and concentrate on the feet because it's impractical to treat the entire summer wardrobes of the six people in my immediate family,' Doug writes, adding that they spray the rest of their clothes and skin with picaridin as needed. That's a perfectly good approach. Personally, though, I get some peace of mind from knowing that my family has a few outfits that are as tick-proofed as any clothes can be — including socks, pants, T-shirts, and hoodies. These are the clothes we'll wear when we're in prime tick territory, pulling up weeds around the unkempt edges of the yard, say, or going hiking with the dog. I'll spend less time second-guessing whether we have enough protection. Insect Shield stitches or stamps an info label onto each item you send in for treatment. Liam McCabe/NYT Wirecutter Thomas Mather, PhD, a professor of public health entomology at the University of Rhode Island and a co-author of the study referenced above, says that fully grown ticks are more likely to hitch a ride above shoe level. 'The adult ones tend to climb up vegetation a little bit' in search of a large host, he says. 'Then you would want to have your socks and pants treated.' (Mather's TickEncounter program at URI has received funding from Insect Shield.) Ticks can also crawl around. I found one on my daughter's scalp this March, and that seemed like a good reason to treat a few shirts, just in case the shoes or pants didn't kill the ticks first. The same study that found the benefits of treated footwear also found that a treated T-shirt can reduce the likelihood of a tick nymph bite by about half. It's a nice bonus that our pesticidal shirts might stop some mosquito bites, too. Cost-wise, the Insect Shield mail-in treatment can be a solid deal compared to manually spraying a set of clothes. If you follow the directions on the Sawyer spray bottle, you use about $3 worth of permethrin spray to treat an outfit at home; you'll need to reapply the spray at least a handful of times throughout tick season, probably to the tune of $15 to $25 per outfit per year. I managed to fit roughly four outfits (four pants, three T-shirts, and three long-sleeves, with enough room leftover for a couple of pairs of socks) into the Insect Shield Your Clothes Easy Pack envelope, which cost $102 with an on-site discount code. (Without the code, it's $120.) So that's about $25 per outfit, in a price range similar to that of spraying clothes yourself across a full tick season, without any of the manual labor. I'm not convinced that the treatment will last as long as Insect Shield claims, but even if I get only one good year of protection (and I think I'll get more than that), it's a solid deal. Mather says that he sends clothes in annually for re-treatment, and Griffin of Insect Shield says that, as far as he knows, reapplication works well. Whereas I used Insect Shield's flat-rate, all-you-can-fit option, the company will also treat individual items for $9 each, or $13.50 for coveralls. That rate doesn't include shipping, as the Easy Pack does, but if you're sending a bunch of bulky items like adult-size pants or long-sleeved shirts made of heavy fabric, you might get more for your money with the per-piece rate. If you're treating a load of socks or kids' clothes, then the Easy Pack is probably the better value. Griffin says that every year Insect Shield treats upward of 50,000 items at the company's facility in North Carolina through its Insect Shield Your Clothes service, and it runs the gamut. 'We see shirts, pants, shorts, T-shirts, hats,' and of course lots of socks, he said. But the company doesn't treat underwear or shoes. It also doesn't treat clothes that can be only dry-cleaned or line-dried, or otherwise not tumble-dried. It can't effectively treat waterproof or water-resistant gear, either. 'It's just really hard to get the permethrin to bond well to those garments,' he said.
Yahoo
13-05-2025
- Yahoo
Creyos Partners with Redox to Eliminate Barriers to Cognitive Health Data in EHRs
Partnership redefines how health systems bring cognitive screening into routine care at scale TORONTO, May 13, 2025 /PRNewswire/ -- Creyos, the leading online platform for objective cognitive and behavioral health assessments, today announced its partnership with Redox, a leading provider of healthcare data interoperability solutions. This strategic collaboration enables large health systems and integrated delivery networks to seamlessly embed Creyos' cognitive testing into their electronic health records (EHRs), eliminating one of the biggest barriers to scaling proactive brain health care. This partnership comes at a time when cognitive and behavioral health assessments are becoming essential to high-quality, preventive care. Over 55 million people worldwide are currently living with dementia, and that number is projected to reach 139 million by 2050. Early and accurate screening is critical for enabling timely intervention, personalized care planning, and improved outcomes. As health systems shift toward value-based care, Creyos is helping providers make cognitive health a core part of routine care. Its tools are clinically proven and easy to implement. Most technology fails to gain traction in large health systems due to poor alignment with clinical workflows. Creyos overcomes this by leveraging Redox's expansive EHR network to deliver seamless data integration and platform access. Its scientifically validated dementia screening and assessments are now available at the point of care, right when providers need them. "We're at a turning point in how health systems approach cognitive health," said Marc Lipton, CEO of Creyos. "To deliver on the promise of value-based care, we need tools that don't just work clinically but also work operationally. This partnership with Redox eliminates the workflow and integration barriers that have slowed adoption for years. It puts Creyos assessments exactly where they need to be, within the systems clinicians already use." Redox's platform supports interoperability across more than 90 EHR systems including, Cerner, eClinicalWorks, and Allscripts, among many others. Health systems deploying Creyos through this partnership can automatically deliver cognitive assessments and patient results to their EHRs without complex, time-consuming IT work. This ensures: Timely Decision-Making: Providers receive screener and assessment data directly in their existing systems, allowing for faster clinical decision making, interventions, and coordinated care planning. Improved Clinical Workflow Efficiency: Automating the integration of cognitive test results reduces administrative burdens, giving providers more time to focus on patient care. Scalability for Large Health Systems: Whether supporting one location or a national network of clinics, the Creyos-Redox integration is highly scalable and adaptable to the unique needs of any enterprise system. Early Detection and Proactive Care: Cognitive health is a critical component of preventive care, especially in aging populations and for at-risk patient groups. By integrating Creyos' cognitive and behavioral assessments directly into EHRs, providers can monitor cognitive decline over time, ensuring they catch early warning signs of conditions such as dementia or mild cognitive impairment (MCI) before they worsen. "Creyos is bringing cognitive health into everyday clinical workflows, and we're proud to power that shift," said Trip Hofer, CEO of Redox. "When results from tools like this are embedded directly into EHR systems, providers can act sooner, and patients benefit from more timely, connected care. This is exactly the kind of integration we believe healthcare needs more of." Creyos EHR integration through Redox is now available for all Creyos customers. Health systems interested in getting Creyos for their practice can learn more by visiting About CreyosCreyos, formerly known as Cambridge Brain Sciences, is a pioneering healthcare technology company dedicated to transforming how healthcare providers assess and manage patient brain health. Supporting clinicians and health systems worldwide, the Creyos platform includes objective online tasks, digital behavioral health screeners, and condition-specific assessments that deliver actionable insights, promote early intervention, and enable evidence-based clinical decisions for various cognitive and behavioral health conditions, including dementia, ADHD, depression, anxiety, and others. Backed by 30 years of research and a normative database of over 85,000 participants, the FDA-registered Creyos platform has been published in over 400 peer reviewed studies and is recognized as a scientifically-validated solution for measuring and monitoring patient brain health. For more information about Creyos visit About RedoxRedox is your highway to better healthcare. We help providers, payers, digital health vendors/independent service providers, EHRs, and Life Sciences companies power better care with seamless data interoperability. Our secure platform's read/write capabilities translate, normalize, and enrich complex healthcare data in real time. With more than 9,600 live connections, organizations across North America use Redox technology to achieve faster speed to value across a wide range of systems, applications, and workflows. For more information, visit or follow us on LinkedIn and X. Media Contact: Erin SmithChief Marketing and Engagement Officer, Creyos(647)- View original content to download multimedia: SOURCE Creyos Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
